CHARLESTON, S.C., March 03, 2017 -- Benefitfocus, Inc. (NASDAQ:BNFT), a leading provider of cloud-based benefits management solutions, today announced that its Chief Executive Officer, Shawn Jenkins, and its Chief Financial Officer, Jeff Laborde, will present at the Raymond James 38th Annual Institutional Investors Conference in Orlando.
The Benefitfocus presentation is scheduled for Tuesday, March 7, 2017 at 9:50 a.m. Eastern Time. The presentation will be available via live webcast and available under the “Events & Presentations” section on the Benefitfocus investor relations website at http://investor.benefitfocus.com/.
About Benefitfocus
Benefitfocus (NASDAQ:BNFT) provides a leading cloud-based benefits management platform that simplifies how organizations and individuals shop for, enroll in, manage and exchange benefits. Every day leading employers, insurance companies and millions of consumers rely on our platform to manage, scale and exchange benefits data seamlessly. In an increasingly complex benefits landscape, we bring order to chaos so our clients and their employees have access to better information, make better decisions and lead better lives. Learn more at www.benefitfocus.com, LinkedIn and Twitter.
Benefitfocus, Inc. 843-284-1052 ext. 3546 [email protected] Investor Relations Michael Bauer 843-284-1052 ext. 6654 [email protected]


Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 



